These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Are newer generation hemoglobin-based oxygen carriers safe: do they offer an answer? Jahr JS. Vascul Pharmacol; 2010 Aug; 52(5-6):214. PubMed ID: 20060496 [No Abstract] [Full Text] [Related]
25. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions]. Labrude P. Ann Pharm Fr; 1992 Aug; 50(5-6):250-66. PubMed ID: 1307671 [Abstract] [Full Text] [Related]
26. Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents. Bucci E. Artif Cells Blood Substit Immobil Biotechnol; 2011 Aug; 39(4):206-13. PubMed ID: 21692690 [Abstract] [Full Text] [Related]
31. An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends. Seghatchian J, de Sousa G. Transfus Apher Sci; 2007 Dec; 37(3):251-9. PubMed ID: 18042438 [Abstract] [Full Text] [Related]
32. A transient inflammatory reaction in the lung after experimental hemorrhagic shock and resuscitation with a hemoglobin-vesicles solution compared with rat RBC transfusion. Yamanashi Y, Mori M, Terajima K, Tsueshita T, Horinouchi H, Sakai H, Sakamoto A. ASAIO J; 2009 Dec; 55(5):478-83. PubMed ID: 19625952 [Abstract] [Full Text] [Related]
33. Future perspectives in blood transfusion. Waschke KF, Quintel M, Kerger H, Lenz C. Acta Anaesthesiol Scand Suppl; 1996 Dec; 109():143-7. PubMed ID: 8901987 [No Abstract] [Full Text] [Related]
34. Setbacks in blood substitutes research and development: a biochemical perspective. Alayash AI. Clin Lab Med; 2010 Jun; 30(2):381-9. PubMed ID: 20513557 [Abstract] [Full Text] [Related]
35. Thermodynamic approach to oxygen delivery in vivo by natural and artificial oxygen carriers. Bucci E. Biophys Chem; 2009 Jun; 142(1-3):1-6. PubMed ID: 19349106 [Abstract] [Full Text] [Related]
36. New transfusion strategies: red cell substitutes. Winslow RM. Annu Rev Med; 1999 Jun; 50():337-53. PubMed ID: 10073282 [Abstract] [Full Text] [Related]
37. Impact of hemoglobin concentration and affinity for oxygen on tissue oxygenation: the case of hemoglobin-based oxygen carriers. Samaja M, Terraneo L. Artif Organs; 2012 Feb; 36(2):210-5. PubMed ID: 21848930 [Abstract] [Full Text] [Related]
39. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example. Chang TM. Artif Cells Blood Substit Immobil Biotechnol; 2006 Feb; 34(6):551-66. PubMed ID: 17090428 [Abstract] [Full Text] [Related]
40. [Current aspects in red blood cell substitutes]. Wang Y, Pan J, Yu Y. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]